Eudaimonia Partners’s Cerence CRNC Stock Holding History

Eudaimonia Partners’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-166	Closed	-$15K	–	566
2021 Q1	$15K	Buy	+166	New	+$18.3K	﹤0.01%	1043

Other funds holding CRNC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Eudaimonia Partners's CRNC Position: Q2 2021 in Review

Eudaimonia Partners sold out of Cerence (CRNC) in Q2 2021, closing a stake of 166 shares — an estimated $15K sold.

Eudaimonia Partners first reported a position in CRNC in Q1 2021 and held it in 1 quarter. The position peaked at $15K in Q1 2021. 342 funds tracked by Wall St. Rank hold CRNC as of Q2 2021.

Eudaimonia Partners reported no remaining Cerence position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 166 Cerence shares in Q2 2021, an estimated $15K.
Eudaimonia Partners first reported a position in Cerence in Q1 2021 and held it in 1 quarter.
Eudaimonia Partners's Cerence position peaked at $15K in Q1 2021.
342 funds tracked by Wall St. Rank held Cerence as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.